Literature DB >> 1906096

Formulary policy for cholesterol reduction.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906096     DOI: 10.1007/bf02598978

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  6 in total

1.  Lowering the cost of lowering the cholesterol: a formulary policy for lovastatin.

Authors:  F A Lederle; E M Rogers
Journal:  J Gen Intern Med       Date:  1990 Nov-Dec       Impact factor: 5.128

Review 2.  Clinical economics. A guide to the economic analysis of clinical practices.

Authors:  J M Eisenberg
Journal:  JAMA       Date:  1989-11-24       Impact factor: 56.272

3.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Authors:  M H Frick; O Elo; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen; V Manninen
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

Review 4.  Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management.

Authors:  K A Schulman; B Kinosian; T A Jacobson; H Glick; M K Willian; H Koffer; J M Eisenberg
Journal:  JAMA       Date:  1990-12-19       Impact factor: 56.272

5.  Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.

Authors:  P L Canner; K G Berge; N K Wenger; J Stamler; L Friedman; R J Prineas; W Friedewald
Journal:  J Am Coll Cardiol       Date:  1986-12       Impact factor: 24.094

6.  Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.

Authors: 
Journal:  Arch Intern Med       Date:  1988-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.